1
David W Robertson, David T Wong, Joseph H Krushinski Jr: 3-aryloxy-3-substituted propanamines. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, June 11, 1991: US05023269 (65 worldwide citation)

The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.


2
Edward E Beedle, David W Robertson, David T Wong: Serotonin antagonists. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 7, 1991: US05013761 (60 worldwide citation)

This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.


3
David W Robertson, David T Wong, Joseph H Krushinski Jr: 3-aryloxy-3-substituted propanamines. Eli Lilly and Company, Robert A Conrad, September 11, 1990: US04956388 (56 worldwide citation)

The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.


4
David W Robertson: Plant mat and method. Grass Ventures, Mason Fenwick & Lawrence, July 13, 1993: US05226255 (36 worldwide citation)

A mat for plant cultivation comprises upper and lower portions of non-woven fibers, substantially all of which are preferably natural, biodegradable fiber; an intermediate layer of bi-laterally stable plastic mesh, of high strength relative to the non-woven fiber layers, is structurally joined to th ...


5
David W Robertson: Ureteral stent with end-effector and related methods. Boston Scientific SciMed, September 27, 2005: US06949125 (27 worldwide citation)

A system and related methods for maintaining the patentcy of the ureter comprising a pusher tube having a pusher tube lumen and an inflate lumen disposed within a wall of the pusher tube and a urinary stent having a proximal and distal portions with an elongated body portion therebetween configured ...


6
David W Robertson, J Scott Hayes: 2-phenylimidazio (4,5-c) pyridines. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, July 19, 1988: US04758574 (23 worldwide citation)

This invention provides for certain 2-phenylimidazo[4,5-c]pyridines, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.


7

8
Jaswant S Gidda, Herbert A Kirst, David W Robertson: Method for treating gastrointestinal disorders. Eli Lilly and Company, Nancy J Harrison, Leroy Whitaker, April 24, 1990: US04920102 (17 worldwide citation)

Novel ring-contracted macrolides which enhance gastrointestinal motility and novel methods and compositions for treating gtastrointestinal disorders in animals with these macrolides and with certain other previously known ring-contracted macrolides are provided.


9
David W Robertson: Inotropic agents. Eli Lilly and Company, Robert A Conrad, October 14, 1986: US04617302 (15 worldwide citation)

This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.


10
Marlene L Cohen, William B Lacefield, David W Robertson: 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT.sub.3 antagonists. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 1, 1990: US04921982 (14 worldwide citation)

This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.



Click the thumbnails below to visualize the patent trend.